Kotak Alts invests Rs 40 Cr in Mediversal Healthcare

image credit- shutterstock

Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 40 crore in Mediversal Healthcare. The round also attracted additional funding from Asha Ventures, an impact focused fund.

The funding will enable Mediversal to undertake both organic and inorganic expansion in the region of Eastern India.

Founded in 2020 by Navneet Ranjan, Bhanu Pratap, and Jayant Gandhi, Mediversal has positioned itself as a trusted name in regional healthcare by combining clinical excellence with affordability. Headquartered in Patna, the multi-specialty hospital chain currently operates a 200+ bed facility and is eyeing expansion in other neighboring districts. With modern infrastructure, efficient systems, and a strong focus on patient-centric care, Mediversal is shaping an East India-centric healthcare ecosystem.

The group holds prestigious accreditations, including Full NABH Certification, IDCCM & IDCCN Compliance, and CAHO ACE Accreditation—among the few in Eastern India to achieve these standards.

Bhanu Pratap, Co-Founder & CEO of Mediversal Healthcare, said, “This investment accelerates our expansion across Bihar and Eastern India. We are opening new hospitals to serve underserved communities with dignified care closer to home. It also strengthens our technological backbone, enabling us to scale seamlessly and uphold consistent standards at every location. Clinical excellence with a human touch remains our defining strength, guided by values of Trust, Transparency, and Care.”

Mediversal has already served over 60,000 patients in the last year across urban and rural towns in Eastern India, reflecting its growing impact and commitment to transforming healthcare access.